Clinical study on Zhou's Qiling Decoction inducing apoptosis of prostate cancer cells through miR-143 / Bcl-2 pathway
Phase 1
Recruiting
- Conditions
- Prostate cancer
- Registration Number
- ITMCTR2100004269
- Lead Sponsor
- Surgical Department I (Urology Department), Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
1. Patients diagnosed with prostate cancer;
2. Patients with complete medical records;
3. Patients aged 50-75 years;
4. Patients with prognosis more than 4 months.
Exclusion Criteria
Patients who have received radiotherapy or chemotherapy.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survival time;
- Secondary Outcome Measures
Name Time Method